The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The research aims to advance scientific understanding and develop new treatments for military-relevant medical conditions through innovative biomedical research. As a prominent private research institution, The Washington University has extensive experience delivering specialized research and development services to federal agencies like the Department of Defense.
Generated 8/13/24, 3:46 AM